Press Releases

AMC Fellowship Press Release - posted October 13, 2017

Protocol Number Protocol Title Date Posted
AMC-045 Phase II Trial of Combined Modality Therapy plus Cetuximab in HIV-Associated Anal Carcinoma April 12, 2017
AMC-048 Modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma October 8, 2015
AMC-042 A Phase II Trial Of Imatinib Mesylate (Gleevec) In Patients With HIV Related Kaposi's Sarcoma February 27, 2015
AMC-061 A Phase I/Pharmacokinetic Study of Sunitinib in Patients with Cancer who also have HIV and are on HAART Therapy July 10, 2014
AMC-047 A Phase II Trial of Doxil, Rituximab, Cyclophosphamide, Vincristine, and Prednisone (DR-COP) in Patients with Newly Diagnosed AIDS-Associated B-Cell Non-Hodgkin’s Lymphoma October 15, 2013
AMC-009 Phase III Study of Paclitaxel Versus Liposomal Doxorubicin for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma October 31, 2011
AMC-034 Randomized Phase II Trial of EPOCH Chemotherapy and Rituximab for HIV-Associated Non-Hodgkin's Lymphoma October 31, 2011
AMC-036 Phase II Trial Of Topical  Halofuginone In Patients With HIV Related Kaposi's Sarcoma October 31, 2011
AMC-038 A Pilot Trial Of Valproic Acid In Patients With Kaposi's Sarcoma October 31, 2011
AMC-052 Testing the Safety of the HPV Vaccine in HIV-Infected Men October 31, 2011